Patent · US Active

Spontaneously dispersible N-benzoyl staurosporine compositions

US8722664B2 · kind B2 · utility

0Cited by

18References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Graham Paul Matthews · Horsham, GB
Barbara Haeberlin · Riehen, CH

Key dates

Filing date	Oct 15, 2013
Grant date	May 13, 2014
Priority date	—
Expiry date	Oct 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/4858
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Spontaneously dispersible N-benzoyl-staurosporine compositions are disclosed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of N-benzoyl-staurosporine, as well as their preparation and use in medical treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.